In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates

CD44 promotes metastasis, chemoresistance, and stemness in different types of cancer and is a target for the development of new anti-cancer therapies. All CD44 isoforms share a common N-terminal domain that binds to hyaluronic acid (HA). Herein, we used a computational approach to design new potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Moreno, Angel J., Reyes-Romero, Atilio, Dömling, Alexander, Velasco-Velázquez, Marco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037692/
https://www.ncbi.nlm.nih.gov/pubmed/33810348
http://dx.doi.org/10.3390/molecules26071877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037692/
https://www.ncbi.nlm.nih.gov/pubmed/33810348
http://dx.doi.org/10.3390/molecules26071877

Ejemplares similares